Literature DB >> 19883159

Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae O1.

Ashraful I Khan1, Fahima Chowdhury, Jason B Harris, Regina C Larocque, Abu S G Faruque, Edward T Ryan, Stephen B Calderwood, Firdausi Qadri.   

Abstract

Vibrio cholerae O1, Ogawa and Inaba serotypes, both cause severe cholera. We compared clinical and immunological features in patients in Bangladesh infected with these 2 serotypes. Blood was collected from hospitalized Ogawa (N=146) or Inaba (N=191) patients at the acute stage (day 2) and 5 and 19 days later. Ogawa patients were younger than Inaba, presented with shorter duration of diarrhoea, and had more frequent abdominal pain, vomiting and need for intravenous fluids (p<0.05). Inaba patients more frequently had dark-field positive stools (p<0.01). Inaba strains were more susceptible to tetracycline and erythromycin than Ogawa strains (p<0.001). Ogawa infection produced higher plasma vibriocidal as well as IgG responses to cholera toxin B subunit, toxin-coregulated pilus subunit and lipopolysaccharide (LPS); higher IgA responses to LPS in 'antibody in lymphocyte supernatant' (ALS) specimens were also seen. These results suggest that a cholera vaccine based on the Ogawa serotype needs to be further investigated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19883159      PMCID: PMC3786431          DOI: 10.3109/00365540903289688

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  44 in total

1.  Epidemic and endemic cholera trends over a 33-year period in Bangladesh.

Authors:  Ira M Longini; Mohammed Yunus; K Zaman; A K Siddique; R Bradley Sack; Azhar Nizam
Journal:  J Infect Dis       Date:  2002-06-17       Impact factor: 5.226

2.  Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial.

Authors:  Wasif A Khan; Debasish Saha; Anisur Rahman; Mohammed A Salam; Joseph Bogaerts; Michael L Bennish
Journal:  Lancet       Date:  2002-11-30       Impact factor: 79.321

3.  Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.

Authors:  C O Tacket; M B Cohen; S S Wasserman; G Losonsky; S Livio; K Kotloff; R Edelman; J B Kaper; S J Cryz; R A Giannella; G Schiff; M M Levine
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

4.  Emergence of Vibrio cholerae O1 biotype El Tor serotype Inaba from the prevailing O1 Ogawa serotype strains in India.

Authors:  P Garg; R K Nandy; P Chaudhury; N R Chowdhury; K De; T Ramamurthy; S Yamasaki; S K Bhattacharya; Y Takeda; G B Nair
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

5.  Diarrhoea in elderly people: aetiology, and clinical characteristics.

Authors:  Abu S G Faruque; Mohammed A Malek; Ashraful I Khan; Sayeeda Huq; Mohammed A Salam; David A Sack
Journal:  Scand J Infect Dis       Date:  2004

6.  Complexity of rice-water stool from patients with Vibrio cholerae plays a role in the transmission of infectious diarrhea.

Authors:  Eric J Nelson; Ashrafuzzaman Chowdhury; Jason B Harris; Yasmin A Begum; Fahima Chowdhury; Ashraful I Khan; Regina C Larocque; Anne L Bishop; Edward T Ryan; Andrew Camilli; Firdausi Qadri; Stephen B Calderwood
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-16       Impact factor: 11.205

7.  Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers.

Authors:  Firdausi Qadri; Edward T Ryan; A S G Faruque; Firoz Ahmed; Ashraful Islam Khan; M Monirul Islam; Syed M Akramuzzaman; David A Sack; Stephen B Calderwood
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh.

Authors:  Fahima Chowdhury; Ashraful I Khan; Jason B Harris; Regina C LaRocque; Mohiul Islam Chowdhury; Edward T Ryan; A S G Faruque; Stephen B Calderwood; Firdausi Qadri
Journal:  Pediatr Infect Dis J       Date:  2008-11       Impact factor: 2.129

Review 9.  Vibrio cholerae and cholera: out of the water and into the host.

Authors:  Joachim Reidl; Karl E Klose
Journal:  FEMS Microbiol Rev       Date:  2002-06       Impact factor: 16.408

10.  Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh.

Authors:  Jason B Harris; Regina C LaRocque; Fahima Chowdhury; Ashraful I Khan; Tanya Logvinenko; Abu S G Faruque; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  PLoS Negl Trop Dis       Date:  2008-04-09
View more
  11 in total

1.  Frequency of reexposure to Vibrio cholerae O1 evaluated by subsequent vibriocidal titer rise after an episode of severe cholera in a highly endemic area in Bangladesh.

Authors:  Ana A Weil; Fahima Chowdhury; Ashraful I Khan; Daniel T Leung; Taher Uddin; Yasmin Ara Begum; Nirod Chandra Saha; Richelle C Charles; Regina C Larocque; Jason B Harris; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  Am J Trop Med Hyg       Date:  2012-09-10       Impact factor: 2.345

2.  Dissecting serotype-specific contributions to live oral cholera vaccine efficacy.

Authors:  Brandon Sit; Bolutife Fakoya; Ting Zhang; Gabriel Billings; Matthew K Waldor
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

3.  Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh.

Authors:  Sweta M Patel; Mohammad Arif Rahman; M Mohasin; M Asrafuzzaman Riyadh; Daniel T Leung; Mohammad Murshid Alam; Fahima Chowdhury; Ashraful I Khan; Ana A Weil; Amena Aktar; Mohammad Nazim; Regina C LaRocque; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri; Jason B Harris
Journal:  Clin Vaccine Immunol       Date:  2012-04-18

4.  Phage Types of Vibrio cholerae 01 Biotype ElTor Strains Isolated from India during 2012-2017.

Authors:  Alok Kumar Chakrabarti; Asim Biswas; Devendra Nath Tewari; Partha Pratim Mondal; Shanta Dutta
Journal:  J Glob Infect Dis       Date:  2020-05-22

5.  The increased severity in patients presenting to hospital with diarrhea in Dhaka, Bangladesh since the emergence of the hybrid strain of Vibrio cholerae O1 is not unique to cholera patients.

Authors:  Fahima Chowdhury; Alison Kuchta; Ashraful Islam Khan; A S G Faruque; Stephen B Calderwood; Edward T Ryan; Firdausi Qadri
Journal:  Int J Infect Dis       Date:  2015-09-25       Impact factor: 3.623

6.  Retrospective Analysis of Serotype Switching of Vibrio cholerae O1 in a Cholera Endemic Region Shows It Is a Non-random Process.

Authors:  Stefan L Karlsson; Nicholas Thomson; Ankur Mutreja; Thomas Connor; Dipika Sur; Mohammad Ali; John Clemens; Gordon Dougan; Jan Holmgren; Michael Lebens
Journal:  PLoS Negl Trop Dis       Date:  2016-10-05

7.  Oral immunization with a probiotic cholera vaccine induces broad protective immunity against Vibrio cholerae colonization and disease in mice.

Authors:  Brandon Sit; Ting Zhang; Bolutife Fakoya; Aklima Akter; Rajib Biswas; Edward T Ryan; Matthew K Waldor
Journal:  PLoS Negl Trop Dis       Date:  2019-05-31

8.  Descriptive epidemiology of cholera outbreak in Nigeria, January-November, 2018: implications for the global roadmap strategy.

Authors:  Kelly Osezele Elimian; Anwar Musah; Somto Mezue; Oyeronke Oyebanji; Sebastian Yennan; Arisekola Jinadu; Nanpring Williams; Adesola Ogunleye; Ibrahima Soce Fall; Michel Yao; Womi-Eteng Eteng; Patrick Abok; Michael Popoola; Martin Chukwuji; Linda Haj Omar; Eme Ekeng; Thieno Balde; Ibrahim Mamadu; Ayodele Adeyemo; Geoffrey Namara; Ifeanyi Okudo; Wondimagegnehu Alemu; Clement Peter; Chikwe Ihekweazu
Journal:  BMC Public Health       Date:  2019-09-13       Impact factor: 3.295

9.  Genomics of the Argentinian cholera epidemic elucidate the contrasting dynamics of epidemic and endemic Vibrio cholerae.

Authors:  Matthew J Dorman; Daryl Domman; Tomás Poklepovich; Charlotte Tolley; Gisella Zolezzi; Leanne Kane; María Rosa Viñas; Marcela Panagópulo; Miriam Moroni; Norma Binsztein; María Inés Caffer; Simon Clare; Gordon Dougan; George P C Salmond; Julian Parkhill; Josefina Campos; Nicholas R Thomson
Journal:  Nat Commun       Date:  2020-10-01       Impact factor: 14.919

10.  Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine.

Authors:  Firdausi Qadri; Ana A Weil; Denise Chac; Taufiqur R Bhuiyan; Amit Saha; Mohammad M Alam; Umme Salma; Nusrat Jahan; Fahima Chowdhury; Ashraful I Khan; Edward T Ryan; Regina LaRocque; Jason B Harris
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.